AGM
FBLG icon

Alpine Global Management’s FibroBiologics FBLG Stock Holding History

Alpine Global Management’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,205
Closed -$120K – 493
2024
Q2 		$120K Buy
+1,205
New +$230K 0.02% 385

Other funds holding FBLG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAS
Optivise Advisory Services Franklin, Tennessee $197M AUM 26.07% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIFAIM
American Institute for Advanced Investment Management Scottsdale, Arizona $173M AUM 25.3% 1-Year Est. Return

Alpine Global Management's FBLG Position: Q3 2024 in Review

Alpine Global Management sold out of FibroBiologics (FBLG) in Q3 2024, closing a stake of 1,205 shares — an estimated $120K sold.

Alpine Global Management first reported a position in FBLG in Q2 2024 and held it in 1 quarter. The position peaked at $120K in Q2 2024. 61 funds tracked by Wall St. Rank hold FBLG as of Q3 2024.

  • Alpine Global Management reported no remaining FibroBiologics position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 1,205 FibroBiologics shares in Q3 2024, an estimated $120K.
  • Alpine Global Management first reported a position in FibroBiologics in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's FibroBiologics position peaked at $120K in Q2 2024.
  • 61 funds tracked by Wall St. Rank held FibroBiologics as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.